Exercise helps prevent low back pain
by Bruce Sylvester: Results from a meta-analysis of relevant studies suggest that exercise, alone or in combination with education, reduces the risk of low back pain. The findings… read more.
by Bruce Sylvester: Results from a meta-analysis of relevant studies suggest that exercise, alone or in combination with education, reduces the risk of low back pain. The findings… read more.
by Bruce Sylvester: Women who have problems sleeping are at an increased risks of developing type 2 diabetes, researchers reported on January 28, 2016 in Diabetologia.
by Bruce Sylvester: Ozone exposure appears to be associated with acute respiratory disease syndrome (ARDS) in some critically ill patients, according to research published on Dec. 17, 2015… read more.
by Bruce Sylvester: Women with heart failure are as likely as men to achieve survival benefit from receiving an implantable cardiac defibrillator, researchers reported on Jan. 12,2016 in Circulation: Heart… read more.
Ixazomib improves progression-free survival across subgroups by Thomas R. Collins: The oral proteasome inhibitor (PI) ixazomib with lenalidomide and dexamethasone (IRd) performed well versus placebo plus lenalidomide and… read more.
Experts try to provide clarity in dizzying myeloma landscape by Thomas R. Collins: There’s no doubt that the bonanza of new multiple myeloma therapies is a blessing to… read more.
ASH 2015 proved to be all that we’d hoped for! We’ve witnessed unprecedented change in multiple myeloma with CR and VGPR percentages higher than ever… and most of this… read more.
by Thomas R. Collins: In early results, patients newly diagnosed with peripheral T-cell lymphoma (PTCL) treated with the HDAC-inhibitor belinostat, and CHOP therapy, tolerated the combination well at… read more.
by Thomas R. Collins: Early results show that venetoclax, a BCL-2-inhibitor, produced relatively good response rates in relapsed or refractory non-Hodgkin lymphoma (NHL) patients.1
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.